Market revenue in 2023 | USD 7.0 million |
Market revenue in 2030 | USD 11.6 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Clinical Trial Design and Consultation Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.57% in 2023. Horizon Databook has segmented the Argentina clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina represents an attractive option for pharmaceutical companies to conduct clinical trials. Presence of well-trained healthcare professionals, a vast network of medical establishments, and relatively low cost of conducting clinical trials in the country in comparison with European & Asian countries are expected to drive the market growth.
In addition, recruitment of patients for clinical trial studies is easier in Argentina, thus covering a large patient pool for the study. Therefore, these advantages and ease of conducting clinical trials in the country are expected to drive the adoption of clinical trial services.
However, absence of national legislation for governing clinical trials in the country increases the probability of errors in clinical trial studies. These flaws in the system for clinical trial studies are expected to hinder the market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Argentina clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account